Palisade Bio Inc
NASDAQ:PALI

Watchlist Manager
Palisade Bio Inc Logo
Palisade Bio Inc
NASDAQ:PALI
Watchlist
Price: 2.08 USD 13.66%
Market Cap: 309.9m USD

Net Margin
Palisade Bio Inc

0%
Current
-1 575%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-14.4m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Palisade Bio Inc
Glance View

Market Cap
309.9m USD
Industry
Pharmaceuticals

Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. The company is headquartered in Carlsbad, California and currently employs 13 full-time employees. The company went IPO on 2006-12-20. The firm is focused on discovering, developing, and commercializing oral therapies that target diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal (GI) tract. Its lead therapeutic candidate, LB1148, is an oral liquid formulation of the digestive enzyme inhibitor, tranexamic acid, intended to inhibit digestive enzyme activity and preserve gut integrity during intestinal stress resulting from, among other things, reduced blood flow to the intestine, infections, or due to surgery. Its LB1148 has been advanced to Phase III clinical trials for the return of bowel function indication, which is a protease inhibitor that helps to restore bowel function and reduce abdominal adhesions following surgery.

PALI Intrinsic Value
0.08 USD
Overvaluation 96%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-14.4m
/
Revenue
0
What is the Net Margin of Palisade Bio Inc?

Based on Palisade Bio Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top